Physician profile
Dorothy Darby
NPI 1689671794
$9,310.51
in general payments reported to CMS, 2019-2025
36 companies · $1,693 in 2025
The $1,693 reported for 2025 was more than what 91% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,780 · 2022: $1,658 · 2023: $2,024 · 2024: $2,157 · 2025: $1,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,872.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,394.11 | 2021-2025 | |
| Pfizer INC. | $1,093.21 | 2021-2025 | |
| Novo Nordisk INC | $879.05 | 2021-2025 | Ozempic |
| Amgen INC. | $806.62 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $749.39 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $493.30 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $394.22 | 2021-2025 | Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $382.08 | 2021-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $367.91 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $357.09 | 2022-2023 | Optimizer |
| Abbott Laboratories | $343.61 | 2021-2025 | Mitraclip, Cardiomems, Jot Dx |
| Alnylam Pharmaceuticals INC. | $262.80 | 2022-2025 | Onpattro, Amvuttra |
| Merck Sharp & Dohme LLC | $238.78 | 2023-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $214.18 | 2022-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $183.49 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $176.15 | 2023-2024 | Barostim Neo System |
| Esperion Therapeutics, INC. | $155.54 | 2021-2023 | Nexletol |
| Shockwave Medical, INC | $129.37 | 2025 | |
| Sanofi-Aventis U.S. LLC | $71.97 | 2023-2024 | |
| Boston Scientific Corporation | $67.34 | 2021-2023 | Watchman Access System |
| Abiomed | $63.65 | 2023-2024 | Impella |
| Regeneron Healthcare Solutions, INC. | $56.86 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $54.96 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $49.37 | 2021-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $44.89 | 2021-2023 | Arcalyst |
| Baxter Healthcare | $41.85 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Inspire Medical Systems, INC. | $41.80 | 2023-2025 | Inspire |
| Itamar Medical INC | $37.46 | 2022 | |
| Cardiva Medical, INC. | $34.07 | 2022 | |
| Irhythm Technologies, INC. | $31.25 | 2024 | Zio Xt Patch, Zio Monitor |
| Atricure, INC. | $22.74 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Arbor Pharmaceuticals, INC. | $17.23 | 2021 | |
| Altathera Pharmaceuticals LLC | $15.12 | 2023 | Sotalol Hydrochloride |
| Scpharmaceuticals INC. | $14.58 | 2024 | |
| Amryt Pharma Holdings Ltd | $12.59 | 2021 | |
| Getinge USA Sales, LLC | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorothy Darby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.